Blog
AbbVie’s Humira Revenue Up 15% (Despite Patent Cliff Fears)
Published by Nicholas McCullum on April 27, 2017
AbbVie (ABBV) was spun off from Abbott Laboratories (ABT) in 2013. Like many spinoffs, AbbVie has outperformed the overall stock market since
AT&T Dials Up a Solid Quarter – But Competitive Threats are Rising
Published by Bob Ciura on April 27th, 2017
AT&T (T) is one of the most tried-and-true dividend stocks in the S&P 500. It has increased its dividend for 33 years in a row.
AT&T is a Dividend
Earn a 7.9% Yield From “Uncle Sam”
Published April 27th, 2017 by Robert Baillieul
This guest post was written by Robert Baillieul, Editor-in-Chief of Income Investors. He advocates for commonsense, buy-and-hold investing. You
How to Position Your Portfolio For The Next Recession: 3 Actionable Steps
Published by Nicholas McCullum on April 26th 2017
The current bull market has lasted 8 years. This is much longer than the typical bull market.
Further, the S&P 500’s price-to-earnings ratio is
3 Real-World Case Studies: How Spinoffs Unlock Shareholder Value
Published by Nicholas McCullum on April 25th, 2017
Investors sometimes face the peculiar scenario of one of their holdings spinning off selected assets as a new, publicly-traded security.
Qualcomm: 4.3% Dividend Yield, With NXP Acquisition a Major Growth Catalyst
Published by Bob Ciura on April 25th, 2017
A 4%+ dividend yield is hard to find in the technology sector, which makes Qualcomm (QCOM) that much more appealing.
Qualcomm stock possesses the rare
Disney’s ESPN Concerns Are Likely Exaggerated: Here’s Why
Published by Nicholas McCullum on April 24th, 2017
Disney (DIS) is the world’s largest entertainment company with a market capitalization of ~$183 billion. The company is famous for its
Preferred Stocks: Performance, Volatility, and Risk-Adjusted Returns
Published by Nicholas McCullum on April 23rd, 2017
Public market investors generally invest in two types of securities: common stocks and bonds.
Commons stocks represent ownership in the
3 Reasons I Prefer PepsiCo Over B&G Foods
Published by Bob Ciura on April 23rd, 2017
PepsiCo (PEP) has an excellent dividend history.
It is a Dividend Aristocrat, a group of companies in the S&P 500 that have raised dividends for 25+
3 Reasons I Prefer Southern Company Over Exelon
Published by Bob Ciura on April 22nd, 2017
Utility stocks are a haven for investors seeking reliable dividend income.
Utilities became known as “widow and orphan” stocks, meaning they were
IBM: Warren Buffett Is Holding On Despite The 5% Decline (And You Should Too)
Published by Bob Ciura on April 22nd, 2017
Shares of International Business Machines (IBM) fell 5% on Wednesday, April 19, after the company posted a disappointing first-quarter earnings
Johnson & Johnson: Modest Price Decline Presents Buying Opportunity
Published by Nicholas McCullum on April 21, 2017
Johnson & Johnson (JNJ) is one of the most stable businesses around.
The company’s statistics are impressive:
33 years of consecutive
W.W. Grainger: Buy the 20% Decline?
Published by Bob Ciura on April 20th, 2017
W.W. Grainger (GWW) has been among the biggest losers in the S&P 500 so far this earnings season. Shares have lost 20% of their value in just the past
REIT Dividend Matchup: Realty Income vs. Omega Healthcare Investors
Published by Bob Ciura on April 20th, 2017
Real Estate Investment Trusts, or REITs as they are more commonly known, are a great source of income.
It is not uncommon to find REITs with dividend
Better Big Pharma Dividend Stock: Pfizer or Teva?
Published by Bob Ciura on April 19th, 2017
Investors can count on the health care sector for dividends.
Pfizer (PFE) and Teva Pharmaceuticals (TEVA) have dividend yields of 3.8% and 4.2%
Is Cardinal Health A Better Bargain Than Ever?
Published on April 18th, 2017 by Nicholas McCullum
The S&P 500 is trading at a historically expensive valuation, propped up by low interest rates, quantitative easing, and positive investor
Better Big Pharma Dividend Stock: AbbVie or Gilead?
Published by Bob Ciura on April 18th, 2017
Pharmaceutical companies are among the strongest dividend growth stocks in the market.
For example, AbbVie (ABBV) and Gilead Sciences (GILD) both
Bill Ackman’s Stock Portfolio: Every Holding Analyzed
Published by Nicholas McCullum on April 17, 2017
Stock screeners allow investors to filter for nearly any quantitative metric. Dividend yields, price-to-earnings ratios, and payout ratios are
Computer Services: A Would-Be Dividend Aristocrat
Published by Nicholas McCullum on April 17, 2017
The Federal Reserve increased interest rates in March, and last December as well. Without a doubt, interest rates are on the rise.
Many
3 Reasons Why Cisco Is A Better Dividend Growth Stock Than Intel
Published by Bob Ciura on April 16th, 2017
The technology sector is a surprisingly good source of dividend stocks.
This wasn’t always the case. During the heyday of the tech sector, hardly any
V.F. Corporation: A New Five-Year Plan
Published April 15th, 2017 by Nicholas McCullum
Long-time shareholders of the V.F. Corporation (VFC) are familiar with the company’s 17×17 plan, which was unveiled in 2013 and aimed at
3 Reasons Target Is Not The Next Sears
Published by Bob Ciura on April 13th, 2017
Target (TGT) is struggling to find its place in the retail landscape.
It is a discount retailer, yet it has trouble competing with Wal-Mart (WMT)
Starbucks: Takeaways From the 2017 Annual Meeting
Published by Nicholas McCullum on April 12, 2017
Starbucks (SBUX) has had a very impressive run since its IPO in 1992. The stock has returned 18,325% during that time period, which has
Walgreens Boots Alliance: Strong Outlook Regardless of Rite Aid Outcome
Published by Nicholas McCullum on April 12, 2017
The consumer staples industry has historically been one of the best for providing strong risk-adjusted returns.
Investors can make these returns
Oaktree Capital Group: 5% Dividend Yield and Growing Assets
Published by Bob Ciura on April 12th, 2017
Investors looking for high yield in the financial sector typically have to look beyond the big banks and insurance companies.
While there are several